← Back to Search

Microneedling Device

Straberi Microneedling Treatment for Atrophic Acne Scars (SAA Trial)

N/A

Waitlist Available

Led By Maurice E Wright, DR

Research Sponsored by Universal Skincare Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

SAA Trial Summary

This trialwill explore a new device for treating acne scars, to make them less noticeable. #MedicalResearch

Eligible Conditions

Atrophic Acne Scars

SAA Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Overall Patient satisfaction of skin improvement assessed by the Goodman and Barons quantitative scar scale.

The Global Aesthetic Improvement Scale (GAIS)

Secondary outcome measures

Overall Skin changes assessed by Acne Scar Subtypes

Overall Skin changes assessed by Derma Scan

Photographs

+1 more

SAA Trial Design

2Treatment groups

Experimental Treatment

Group I: Straberi Microneedling TreatmentExperimental Treatment1 Intervention

Non-Randomized treatment for patients with atrophic acne skin conditions using the Straberi Microneedling device.

Group II: Patiant without treatmentExperimental Treatment1 Intervention

Non-Randomized patients with atrophic acne skin conditions

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Straberi

2022

N/A

~30

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Lavish BeautyUNKNOWN

2 Previous Clinical Trials

60 Total Patients Enrolled

Universal Skincare InstituteLead Sponsor

2 Previous Clinical Trials

60 Total Patients Enrolled

Leslie L NesbittStudy ChairUniversal Skincare

2 Previous Clinical Trials

60 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there specific eligibility requirements to participate in this medical trial?

"To take part in this investigation, applicants must have atrophic acne scars and be between 21-65 years old. A total of 25 participants are accepted into the trial."

Answered by AI

Are there any vacant positions for participants in this research program?

"This research is actively seeking participants, with the original trial post occuring on November 21st 2022 and a recent update made on October 27th of the same year."

Answered by AI

To what end is this research endeavor being conducted?

"This 6-month clinical trial targets the Global Aesthetic Improvement Scale (GAIS) as its primary outcome. As secondary objectives, the [Acne scar](https://www.withpower.com/clinical-trials/acne-scar) Subtypes and Derma Scan System are employed to measure improvement in skin condition while Photographs are used to quantify acne scar improvements on a quartile grading scale."

Answered by AI

Does this experiment accept those under the age of fifty?

"As indicated by the eligibility requirements, this trial is only open to individuals aged 21-65 years old. However, there are alternate trials with 43 slots for minors and 139 spots available for seniors."

Answered by AI

To what extent is this research being conducted with the participation of human subjects?

"Indeed, according to clinicaltrials.gov, this research is currently enrolling individuals. It was first publicized on November 21st 2022 and the most recent changes were made October 27th of last year. 25 study participants are required at two sites for completion."

Answered by AI

Recent research and studies

Clinical and Experimental DermatologyJournal

Dermatology Life Quality Index (dlqi)-a Simple Practical Measure for Routine Clinical Use

FINLAY, A.Y., and G.K. KHAN. 1994. “Dermatology Life Quality Index (dlqi)-a Simple Practical Measure for Routine Clinical Use”. Clinical and Experimental Dermatology. Wiley. doi:10.1111/j.1365-2230.1994.tb01167.x.

clinicaltrials.govStudy

Straberi Microneedling For Atrophic Acne

2022. "Straberi Microneedling For Atrophic Acne". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04740268.